MODIFICATION TO MARSPO2, MODEL 2001— 510(k) K000794

Substantially Equivalent

Novametrix Medical Systems, Inc.

FDA 510(k) clearance K000794 for MODIFICATION TO MARSPO2, MODEL 2001, Substantially Equivalent on 2000-04-10. Applicant: Novametrix Medical Systems, Inc..

Clearance details

Applicant: Novametrix Medical Systems, Inc.
Product code: Code DQA
Advisory panel: Cardiovascular
Date received: 2000-03-13
Decision date: 2000-04-10
Decision: Substantially Equivalent
Clearance type: Special
Location: Wallingford, CT, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQA

product code DQA

Death: 66
Malfunction: 2,867
Other: 1
Total: 2,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.